Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Pegcrisantaspase |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
Pegcrisantaspase is a recombinant PEGylated asparaginase derived from Erwinia chrysanthemi, which potentially inhibits cell proliferation and tumor growth (PMID: 29090524, Cancer Res 2020;80(16 Suppl):Abstract nr 4047). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C170297 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cytarabine + Fludarabine + Pegcrisantaspase | Cytarabine Fludarabine Pegcrisantaspase | 0 | 1 |
| Pegcrisantaspase | Pegcrisantaspase | 0 | 0 |
| Pegcrisantaspase + Venetoclax | Pegcrisantaspase Venetoclax | 0 | 1 |